Results 131 to 140 of about 3,073 (184)
FAIR and Square: Privacy Compliance Framework for Healthcare Databases
Zhu Z +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Plasma chlorpropamide: A critical factor in chlorpropamide-alcohol flush
European Journal of Clinical Pharmacology, 1983The chlorpropamide-alcohol flush (CPAF) phenomenon was quantitatively related to blood levels of acetaldehyde and chlorpropamide in 105 Type II diabetics, of whom 74 had not previously taken the drug and 31 were on chronic treatment. Standardized skin temperature recordings were made with a sensitive probe.
Peter Jerntorp, L O Almer, Hans Ohlin
exaly +3 more sources
Pediatrics, 1968
Clinical signs of hypoglycemia developed in a 3½-year-old boy 24 hours after he had eaten some of the attractively blue-colored chlorpropamide tablets. Low blood sugar values persisted for 4 days after the ingestion concomitant with an increase in serum insulin concentration. On the fifth day, the blood sugar rose to normal levels.
B, Greenberg, C, Weihl, G, Hug
openaire +2 more sources
Clinical signs of hypoglycemia developed in a 3½-year-old boy 24 hours after he had eaten some of the attractively blue-colored chlorpropamide tablets. Low blood sugar values persisted for 4 days after the ingestion concomitant with an increase in serum insulin concentration. On the fifth day, the blood sugar rose to normal levels.
B, Greenberg, C, Weihl, G, Hug
openaire +2 more sources
Chlorpropamide in the Management of Diabetes
Archives of Internal Medicine, 1959Chlorpropamide is a new oral antidiabetic agent. Its chemical name isN-propyl-N'-(p-chloro-benzenesulfonyl)urea. The structural formula (Fig. 1) is similar to other sulfonamide derivatives which have been observed to have a blood-sugar-lowering effect.
S J, SUGAR, L J, THOMAS, T M, EUGENIO
openaire +2 more sources